3.27% -0.0321

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals (RIGL) 最新ニュース

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals (RIGL) 最新ニュース

Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Movies UK

Rigel Pharmaceuticals : to Participate in Citi's 15th Annual BioPharma Virtual Conference - Marketscreener.com

Bullish Rigel Pharmaceuticals Insiders Rewarded As Their Investment Rises To US$1.5m \ - Yahoo Lifestyle UK

ZTS: 3 Pharma Stocks With May Potential - StockNews.com

HC Wainwright Weighs in on Rigel Pharmaceuticals, Inc.'s FY2026 Earnings (NASDAQ:RIGL) - MarketBeat

HC Wainwright Weighs in on Rigel Pharmaceuticals, Inc.'s FY2026 Earnings (NASDAQ:RIGL) - Defense World

Rigel Pharmaceuticals (RIGL) Stock Forecast and Price Target 2024 - MarketBeat

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Expected to Earn FY2024 Earnings of $0.05 Per Share - Defense World

Rigel Pharmaceuticals (NASDAQ:RIGL) Lifted to “Buy” at StockNews.com - Defense World

Rigel Pharmaceuticals, Inc. Expected to Post FY2024 Earnings of $0.05 Per Share (NASDAQ:RIGL) - MarketBeat

Rigel (RIGL) Upgraded to Buy: Here's What You Should Know - MSN

Rigel (RIGL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance Australia

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance

Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Reiterated by HC Wainwright - Defense World

Oncology - Acute myeloid leukemia, Hematology - The Pharma Letter

Oncology - Acute myeloid leukemia, Research - The Pharma Letter

Oncology - Acute myeloid leukemia, Biotechnology - The Pharma Letter

Oncology - Acute myeloid leukemia, Oncology - The Pharma Letter

Oncology - olutasidenib, Rigel Pharmaceuticals - The Pharma Letter

Rigel Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Earnings call: Rigel Pharmaceuticals Q1 2024 performance and outlook - Investing.com Nigeria

Rigel Pharmaceuticals' (RIGL) Buy Rating Reiterated at HC Wainwright - MarketBeat

Earnings call: Rigel Pharmaceuticals Q1 2024 performance and outlook - Investing.com India

Earnings call: Rigel Pharmaceuticals Q1 2024 performance and outlook - Investing.com UK

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript - Yahoo Finance

Rigel Pharmaceuticals (NASDAQ:RIGL) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat

Rigel: Q1 Earnings Snapshot - Houston Chronicle

Rigel Pharmaceuticals Inc (RIGL) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves and Financial Insights - GuruFocus.com

Rigel Pharmaceuticals (NASDAQ:RIGL) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat

RIGL Stock Earnings: Rigel Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 - MSN

RIGL Stock Earnings: Rigel Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 - MSN

Warm Autoimmune Hemolytic Anemia Market to Observe Significant Growth During the Forecast Period | Rigel ... - Barchart

Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Lags Revenue Estimates

Rigel Reports First Quarter 2024 Financial Results and Provides Business Update - PR Newswire

Rigel: Q1 Earnings Snapshot - Houston Chronicle

Investors in Rigel Pharmaceuticals (NASDAQ:RIGL) have unfortunately lost 68% over the last five years - Yahoo New Zealand News

ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Little Excitement Around Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Revenues As Shares Take 29% Pounding - Simply Wall St

Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates

Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update - Yahoo Finance UK

Rigel: No Respect With Little Justification, Worth Considering A Buy (NASDAQ:RIGL) - Seeking Alpha

Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR Newswire

Market Sentiment Around Loss-Making Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Simply Wall St

Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Singapore News

Rigel's new skin-penetrant IRAK-1/4 inhibitor shows promise for psoriasis - BioWorld Online

Rigel Pharmaceuticals names new Chief Medical Officer By Investing.com - Investing.com

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Simply Wall St

Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year - Yahoo Finance

RIGLに似た銘柄